- Report
- October 2024
- 185 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 92 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- March 2025
- 508 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- December 2023
- 162 Pages
Global
From €2362EUR$2,475USD£1,979GBP
€4724EUR$4,950USD£3,958GBP
- Report
- November 2023
- 188 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2022
- 115 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2023
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- January 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- November 2023
- 253 Pages
Global
€4767EUR$4,995USD£3,994GBP
- Report
- May 2023
- 73 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- February 2022
- 132 Pages
Global
From €811EUR$850USD£680GBP
- Report
- June 2022
- 210 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Book
- May 2023
North America

Intraoperative Radiation Therapy (IORT) is a form of radiotherapy used during surgery to treat cancer. It is a type of external beam radiotherapy, where a single dose of radiation is delivered directly to the tumor site during surgery. This allows for a higher dose of radiation to be delivered to the tumor, while sparing healthy tissue from radiation exposure. IORT is used to treat a variety of cancers, including breast, prostate, and colorectal cancer.
IORT is typically used in combination with other treatments, such as chemotherapy or surgery. It is often used to treat tumors that are difficult to reach with traditional radiotherapy, or to reduce the risk of recurrence after surgery. IORT is also used to treat tumors that are too large to be removed surgically.
IORT is a rapidly growing field, with many companies offering products and services related to the technology. Companies such as Elekta, Varian Medical Systems, and Accuray offer IORT systems, while companies such as CIVCO Medical Solutions and IsoRay Medical provide accessories and services related to IORT. Show Less Read more